4974 — Takara Bio Share Price

As of Today at 19:21 UTC, shares in Takara Bio are trading at ¥956. This share price information is delayed by 15 minutes.

Shares in Takara Bio last closed at ¥956 and the price had moved by -45.25% over the past 365 days. In terms of relative price strength the Takara Bio share price has underperformed the Nikkei 225 Index by -58.79% over the past year.

The overall consensus recommendation for Takara Bio is Buy. You can view the full broker recommendation list by unlocking its StockReport.

The Takara Bio dividend yield is 4.39% based on the trailing twelve month period.

Last year, Takara Bio paid a total dividend of ¥42, and it currently has a trailing dividend yield of 4.39%.Looking ahead, the next dividend pay date is 2024-06-01.

We do not have data on when Takara Bio is to next pay dividends.  The historic dividend yield on Takara Bio shares is currently 4.39%.

To buy shares in Takara Bio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of ¥956, shares in Takara Bio had a market capitalisation of ¥115bn.

Here are the trading details for Takara Bio: 

• Country of listing: Japan
• Exchange: TYO
• Ticker Symbol: 4974

Based on an overall assessment of its quality, value and momentum Takara Bio is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

The analyst consensus target price for shares in Takara Bio is ¥1,840.  That is 92.47% above the last closing price of ¥956.

Analysts covering Takara Bio currently have a consensus Earnings Per Share (EPS) forecast of ¥17 for the next financial year.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like Takara Bio. Over the past six months, its share price has underperformed the Nikkei 225 Index by -39.53%.

As of the last closing price of ¥956, shares in Takara Bio were trading -25.51% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The Takara Bio PE ratio based on its reported earnings over the past 12 months is 29.78. The shares last closed at ¥956. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Takara Bio's management team is headed by: 

• Hisashi Ohmiya - CHM
• Koichi Nakao - PRE
• Yoh Hamaoka - CFO
• Junichi Mineno - COO
• Tsuyoshi Miyamura - CMO
• Mutsumi Sano - SME
• Masanobu Kimura - MEO
• Katsuhiko Kusakabe - MEO
• Kazuki Yamamoto - MEO
• Akira Kodera - DSL
• Kyoko Nakajima - DSL
• Noritaka Nishiwaki - DHR
• Takuya Kakemi - EXO
• Masanari Kitagawa - EXO
• Nobuto Koyama - EXO
• Nobuko Kawashima - IND
• Kazuko Kimura - IND
• Noriomi Matsumura - IND